TIVOPATH (tivozanib hydrochloride), created in 2012 (United States), from 13 sister brands. TIVOPATH (tivozanib hydrochloride) is owned by Aveo Pharmaceuticals, listed on the stock exchange of New York The sector of TIVOPATH (tivozanib hydrochloride) is Divers.
Share price and profitability of the share Aveo Pharmaceuticals (TIVOPATH (tivozanib hydrochloride))
Buy Aveo Pharmaceuticals share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Stock market history Aveo Pharmaceuticals (TIVOPATH (tivozanib hydrochloride))
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
